View Latest Recalls
NOTICE: Do not rely on KitchenAttendant to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.


May 15, 2019

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination

Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site.